Secondary hypertension

H. Kawabe, I. Saito

Research output: Contribution to journalArticle

Abstract

In patients with hypertension and chronic renal parenchymal disease, BP should be controlled to 130/85 mmHg or lower (125/75 mmHg) in patients with proteinuria in excess of 1 g/day. Reducing dietary sodium (< 7 g/day) and protein (< 0.6-0.7 g/kg) helps control high BP and renal function in patients with renal insufficiency. As first antihypertensive drug, ACE inhibitors or long-acting Ca antagonists are recommended. In patients with renovascular hypertension, angioplasty is the first choice increasingly to be accompanied by stenting, and surgical revascularization is the next choice. As antihypertensive drugs, beta blockers, ACE inhibitors, and AII-receptor blockers are recommended. Hypertension accompanied by endocrine disease with adenoma or tumor is almost cured or improved by surgical removal. Spironolactone and Ca antagonists are used in patients with idiopathic aldosteronism (bilateral hyperplasia). Alpha and beta blockers are used in patients with pheochromocytoma during preoperative period.

Original languageEnglish
Pages (from-to)938-944
Number of pages7
JournalNippon rinsho. Japanese journal of clinical medicine
Volume59
Issue number5
Publication statusPublished - 2001

Fingerprint

Hypertension
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Dietary Sodium
Preoperative Period
Endocrine System Diseases
Renovascular Hypertension
Spironolactone
Hyperaldosteronism
Pheochromocytoma
Chronic Renal Insufficiency
Angioplasty
Proteinuria
Adenoma
Hyperplasia
Renal Insufficiency
Kidney
Neoplasms
Proteins

Cite this

Kawabe, H., & Saito, I. (2001). Secondary hypertension. Nippon rinsho. Japanese journal of clinical medicine, 59(5), 938-944.

Secondary hypertension. / Kawabe, H.; Saito, I.

In: Nippon rinsho. Japanese journal of clinical medicine, Vol. 59, No. 5, 2001, p. 938-944.

Research output: Contribution to journalArticle

Kawabe, H & Saito, I 2001, 'Secondary hypertension', Nippon rinsho. Japanese journal of clinical medicine, vol. 59, no. 5, pp. 938-944.
Kawabe, H. ; Saito, I. / Secondary hypertension. In: Nippon rinsho. Japanese journal of clinical medicine. 2001 ; Vol. 59, No. 5. pp. 938-944.
@article{17c37f7edf9b4fcd8339839338ac81f6,
title = "Secondary hypertension",
abstract = "In patients with hypertension and chronic renal parenchymal disease, BP should be controlled to 130/85 mmHg or lower (125/75 mmHg) in patients with proteinuria in excess of 1 g/day. Reducing dietary sodium (< 7 g/day) and protein (< 0.6-0.7 g/kg) helps control high BP and renal function in patients with renal insufficiency. As first antihypertensive drug, ACE inhibitors or long-acting Ca antagonists are recommended. In patients with renovascular hypertension, angioplasty is the first choice increasingly to be accompanied by stenting, and surgical revascularization is the next choice. As antihypertensive drugs, beta blockers, ACE inhibitors, and AII-receptor blockers are recommended. Hypertension accompanied by endocrine disease with adenoma or tumor is almost cured or improved by surgical removal. Spironolactone and Ca antagonists are used in patients with idiopathic aldosteronism (bilateral hyperplasia). Alpha and beta blockers are used in patients with pheochromocytoma during preoperative period.",
author = "H. Kawabe and I. Saito",
year = "2001",
language = "English",
volume = "59",
pages = "938--944",
journal = "Nihon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "5",

}

TY - JOUR

T1 - Secondary hypertension

AU - Kawabe, H.

AU - Saito, I.

PY - 2001

Y1 - 2001

N2 - In patients with hypertension and chronic renal parenchymal disease, BP should be controlled to 130/85 mmHg or lower (125/75 mmHg) in patients with proteinuria in excess of 1 g/day. Reducing dietary sodium (< 7 g/day) and protein (< 0.6-0.7 g/kg) helps control high BP and renal function in patients with renal insufficiency. As first antihypertensive drug, ACE inhibitors or long-acting Ca antagonists are recommended. In patients with renovascular hypertension, angioplasty is the first choice increasingly to be accompanied by stenting, and surgical revascularization is the next choice. As antihypertensive drugs, beta blockers, ACE inhibitors, and AII-receptor blockers are recommended. Hypertension accompanied by endocrine disease with adenoma or tumor is almost cured or improved by surgical removal. Spironolactone and Ca antagonists are used in patients with idiopathic aldosteronism (bilateral hyperplasia). Alpha and beta blockers are used in patients with pheochromocytoma during preoperative period.

AB - In patients with hypertension and chronic renal parenchymal disease, BP should be controlled to 130/85 mmHg or lower (125/75 mmHg) in patients with proteinuria in excess of 1 g/day. Reducing dietary sodium (< 7 g/day) and protein (< 0.6-0.7 g/kg) helps control high BP and renal function in patients with renal insufficiency. As first antihypertensive drug, ACE inhibitors or long-acting Ca antagonists are recommended. In patients with renovascular hypertension, angioplasty is the first choice increasingly to be accompanied by stenting, and surgical revascularization is the next choice. As antihypertensive drugs, beta blockers, ACE inhibitors, and AII-receptor blockers are recommended. Hypertension accompanied by endocrine disease with adenoma or tumor is almost cured or improved by surgical removal. Spironolactone and Ca antagonists are used in patients with idiopathic aldosteronism (bilateral hyperplasia). Alpha and beta blockers are used in patients with pheochromocytoma during preoperative period.

UR - http://www.scopus.com/inward/record.url?scp=0035350077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035350077&partnerID=8YFLogxK

M3 - Article

C2 - 11391995

AN - SCOPUS:0035350077

VL - 59

SP - 938

EP - 944

JO - Nihon rinsho. Japanese journal of clinical medicine

JF - Nihon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 5

ER -